Related Experiment Video
Updated: Oct 3, 2025

Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
Published on: July 12, 2024
Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus
Betty Raman1, David A Bluemke2,3, Thomas F Lüscher4,5
1Division of Cardiovascular Medicine, Radcliffe Department of Medicine, Oxford Centre for Clinical Magnetic Resonance Research, University of Oxford, National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Headley Way, Oxford OX3 9DU, UK.
Insights
Long COVID, persistent symptoms beyond 3 months post-COVID-19 infection, significantly impacts cardiovascular and cardiopulmonary health. Understanding these long COVID sequelae is crucial for patient management and future research.
Area of Science:
- Cardiology
- Infectious Diseases
- Pulmonology
Background:
- Long COVID, or post-acute sequelae of COVID-19, affects millions globally with persistent symptoms.
- Cardiopulmonary and autonomic dysfunction are common, leading to significant disability and anxiety.
- Cardiovascular abnormalities like myocardial inflammation and arrhythmias are increasingly reported post-COVID-19.
Purpose of the Study:
- To review the definition, epidemiology, and cardiopulmonary symptoms of long COVID.
- To explore pathophysiological mechanisms of acute and chronic cardiovascular injury post-COVID-19.
- To discuss the impact of COVID-19 on multiorgan health and propose a referral model for cardiac services.
Main Methods:
- Literature review focusing on long COVID, cardiopulmonary symptoms, and cardiovascular sequelae.
- Analysis of pathophysiological mechanisms underlying acute and chronic cardiovascular injury.
- Examination of COVID-19's impact on multiorgan health and proposed clinical pathways.
Main Results:
- Long COVID presents with diverse cardiopulmonary symptoms and autonomic manifestations.
- Significant cardiovascular abnormalities, including myocardial inflammation and dysfunction, persist post-acute infection.
- Mechanisms linking ongoing symptoms to objective health measures require further elucidation.
Conclusions:
- Long COVID poses a substantial long-term health burden, particularly affecting cardiovascular and cardiopulmonary systems.
- Further research into pathophysiological mechanisms and clinical trials are essential for effective treatment strategies.
- A structured approach to cardiac referral is proposed for managing post-COVID-19 cardiovascular sequelae.
Abstract:
Emerging as a new epidemic, long COVID or post-acute sequelae of coronavirus disease 2019 (COVID-19), a condition characterized by the persistence of COVID-19 symptoms beyond 3 months, is anticipated to substantially alter the lives of millions of people globally. Cardiopulmonary symptoms including chest pain, shortness of breath, fatigue, and autonomic manifestations such as postural orthostatic tachycardia are common and associated with significant disability, heightened anxiety, and public awareness. A range of cardiovascular (CV) abnormalities has been reported among patients beyond the acute phase and include myocardial inflammation, myocardial infarction, right ventricular dysfunction, and arrhythmias. Pathophysiological mechanisms for delayed complications are still poorly understood, with a dissociation seen between ongoing symptoms and objective measures of cardiopulmonary health. COVID-19 is anticipated to alter the long-term trajectory of many chronic cardiac diseases which are abundant in those at risk of severe disease. In this review, we discuss the definition of long COVID and its epidemiology, with an emphasis on cardiopulmonary symptoms. We further review the pathophysiological mechanisms underlying acute and chronic CV injury, the range of post-acute CV sequelae, and impact of COVID-19 on multiorgan health. We propose a possible model for referral of post-COVID-19 patients to cardiac services and discuss future directions including research priorities and clinical trials that are currently underway to evaluate the efficacy of treatment strategies for long COVID and associated CV sequelae.
More Related Videos
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
08:25Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Acute Coronary Syndrome V: Nursing Management
Cardiomyopathy VI: Nursing Management